Trial Profile
A prospective study investigating the effect regiments containing bevacizumab, pemetrexed, cisplatin or carboplatin on quality of life in patients with non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Pemetrexed (Primary) ; Carboplatin; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 16 Oct 2015 New trial record